MedAvail Holdings, Inc.
MDVL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $43 | $22 | $14 | $4 |
| % Growth | 94.8% | 58.4% | 270.4% | – |
| Cost of Goods Sold | $41 | $22 | $9 | $3 |
| Gross Profit | $3 | $0 | $5 | $1 |
| % Margin | 6% | 1.4% | 37% | 25.1% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $23 | $22 | $17 | $16 |
| SG&A Expenses | $32 | $29 | $20 | $19 |
| Sales & Mktg Exp. | $8 | $7 | $3 | $3 |
| Other Operating Expenses | $16 | $13 | $6 | $2 |
| Operating Expenses | $49 | $44 | $26 | $22 |
| Operating Income | -$46 | -$44 | -$21 | -$21 |
| % Margin | -107.7% | -196.6% | -149% | -549.1% |
| Other Income/Exp. Net | -$1 | -$0 | -$6 | -$1 |
| Pre-Tax Income | -$48 | -$44 | -$27 | -$22 |
| Tax Expense | $0 | $0 | -$1 | $1 |
| Net Income | -$48 | -$44 | -$26 | -$22 |
| % Margin | -110.5% | -198% | -187.1% | -590.5% |
| EPS | -36.2 | -67.08 | -228.38 | -691.31 |
| % Growth | 46% | 70.6% | 67% | – |
| EPS Diluted | -36.2 | -67.08 | -228.38 | -691.29 |
| Weighted Avg Shares Out | 1 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | -$0 | $2 |
| EBITDA | -$46 | -$43 | -$19 | -$19 |
| % Margin | -107.7% | -194% | -136.1% | -504.4% |